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Introduction
Chromosomes in interphase cells occupy nonrandom radial 
and relative positioning (Parada et al., 2004). The basis for 
this likely depends on many factors that restrict an otherwise 
random distribution. The accumulation of heterochromatin 
domains from one or more chromosomes can take place along 
the lamina at the nuclear periphery. Likewise, the constitutive 
heterochromatin accumulations in mouse cells, called chro-
mocenters, often consist of heterochromatic loci contributed 
from several chromosomes. Thus, heterochromatin domains 
can restrict the relative and radial orientation of chromosomes. 
Similarly, chromosomes that share transcription-activating 
factors, such as those that possess nucleolar organizing re-
gions, will be restricted in their relative localization because 
they have to come together to form a nucleolus. Specific tran-
scribed genes have also been shown to colocalize at nuclear 
speckles (Shopland et al., 2003) and in transcription factories 
(Osborne et al., 2004). These discrete subnuclear domains all con-
tribute to a three-dimensionally structured genome (Spector, 
2001). Spatial and temporal relationships between chromatin 
and subnuclear compartments are likely to have profound 
regulatory effects under physiological and developmental 
conditions (Misteli, 2007). Identifying these relationships is 
critically important for understanding the regulation of nu-
clear events.
Another subnuclear compartment that we and others have 
hypothesized may interact nonrandomly with the genome is the 
promyelocytic leukemia nuclear body (PML NB). The main 
constituent of this nuclear body is the PML protein itself. More 
than 60 other proteins may accumulate in these bodies under 
certain conditions, thereby implicating this compartment in a 
variety of nuclear activities (Dellaire and Bazett-Jones, 2004). 
A general model for PML NB function, however, has remained 
elusive. Although the core structure of a typical PML NB is 
protein-based, containing no detectable DNA, this protein core 
does appear to make numerous contacts with the surrounding 
chromatin (Boisvert et al., 2000). It is tempting to hypothesize 
that PML NB–chromatin contacts reflect an underlying func-
tion of these bodies.
Important insights into nuclear function would arise if gene loci physically interacting with particular sub­nuclear domains could be readily identified. Immuno­
fluorescence microscopy combined with fluorescence 
in situ hybridization (immuno­FISH), the method that would 
typically be used in such a study, is limited by spatial reso­
lution and requires prior assumptions for selecting genes 
to probe. Our new technique, immuno­TRAP, overcomes 
these limitations. Using promyelocytic leukemia nuclear 
bodies (PML NBs) as a model, we used immuno­TRAP to 
determine if specific genes localize within molecular di­
mensions with these bodies. Although we confirmed a TP53 
gene–PML NB association, immuno­TRAP allowed us to 
uncover novel locus­PML NB associations, including the 
ABCA7 and TFF1 loci and, most surprisingly, the PML locus 
itself. These associations were cell type specific and re­
flected the cell’s physiological state. Combined with mi­
croarrays or deep sequencing, immuno­TRAP provides 
powerful opportunities for identifying gene locus associa­
tions with potentially any nuclear subcompartment.
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Results
Isolation of DNA associated with PML NBs 
using immuno-TRAP
To isolate DNA associated at molecular dimensions with PML 
NBs, we modified the RNA tagging and recovery of associated 
proteins (TRAP) method developed by Fraser and colleagues 
to deposit biotin onto the chromatin through a biotin-tyramide 
reagent (Carter et al., 2002). RNA TRAP was originally de-
veloped to describe the chromatin organization around the 
transcribing -globin gene in liver cells from mouse embryos 
(Carter et al., 2002). We modified the protocol by using anti-
bodies targeted against PML protein to localize the required 
peroxidase activity around PML NBs, and, therefore, named the 
modified protocol immuno-TRAP (Fig. 1 A). In brief, an anti-
body against PML protein is used to label fixed and permeabi-
lized cells. A secondary antibody conjugated with horseradish 
peroxidase is added. This localizes the peroxidase activity to 
PML NBs and catalyzes the deposition of biotinylated tyra-
mide to protein in the immediate vicinity of PML NBs. Once 
the deposition is complete, the cells are collected and the DNA 
purified. We chose to test the feasibility of immuno-TRAP using 
the Jurkat cell line because a previous study using immuno-
FISH had demonstrated that the TP53 locus was associated with 
PML NBs, in contrast to the BCL2 locus, which was not associ-
ated (Sun et al., 2003). Thus, these two loci serve as suitable pos-
itive and negative controls for the immuno-TRAP technique.
To determine if biotin-tyramide deposition was specifically 
confined to PML NBs, immuno-TRAP was performed on fixed 
and permeabilized Jurkat cells before examination with fluor-
escence microscopy. The biotin-tyramide deposition was de-
tected with streptavidin conjugated with the Cy3 fluorophore. 
As shown in Fig. 1 B, tyramide deposition was confined to PML 
NBs as observed by the colocalization of streptavidin and PML 
immunofluorescence signal. When a nonspecific anti-FLAG pri-
mary antibody was used as a control, followed by the peroxidase-
tagged secondary antibody, no detectable tyramide deposition 
at PML NBs was observed. In addition, DNA could only be puri-
fied by streptavidin agarose beads when the anti-PML and not 
the anti-FLAG antibody was used (Fig. 1 C). Collectively, we 
conclude that immuno-TRAP is capable of tagging chromatin on 
the basis of its proximity to PML NBs. This tagging is within the 
molecular dimensions of primary and secondary antibodies.
Having demonstrated that immuno-TRAP is capable of 
depositing tyramide specifically to PML NBs, the next step was 
to confirm whether specific loci could be detected. To test the 
specificity, we performed immuno-TRAP on Jurkat cells and 
used the affinity-purified DNA as a probe for a DNA dot blot 
spotted with a set of BACs spanning chromosome 17p13.2-13.1, 
one of which contains the TP53 gene, and another BAC from 
chromosome 18 that contains the BCL2 locus (Table S1). Quan-
tification of enrichment of DNA sequences along chromosome 17, 
relative to the BCL2 locus, revealed that our immuno-TRAP 
method had indeed enriched the TP53 locus (Fig. 1, D and E, 
arrow). Moreover, with immuno-TRAP we were able to iden-
tify genomic regions, peaks 1–3 (see Table S2 for a list of genes 
contained within BACs), which are even more enriched than 
To understand the functional importance and regulatory 
potential of subnuclear compartments, methods are required that 
can identify the genetic loci that are localized there. Two main 
approaches that can define a link between a protein component 
of the cell’s regulatory machinery and a genetic locus both use 
specific antibodies against the protein factor. These have been 
used to identify the relationship between PML protein and specific 
genes. Chromatin immunoprecipitation (ChIP), one of these 
techniques, allows for the identification of DNA sequences that 
are mediated either with a direct interaction with a protein of 
interest or indirectly through a multiprotein complex. Studies 
using ChIP have identified specific regions of the genomes that 
are bound by PML protein (Kumar et al., 2007; Gialitakis et al., 
2010). However, a serious limitation of this method is that by 
using an antibody against PML protein, ChIP cannot differ-
entiate between chromatin interactions with PML in nuclear 
bodies versus with PML protein dispersed throughout the nu-
cleoplasm. A second drawback of ChIP is that it works opti-
mally with soluble proteins. Unfortunately, a large fraction of 
PML protein is found in an insoluble nuclear matrix (Chang 
et al., 1995). Chromatin associated with this insoluble compo-
nent would not be represented in a ChIP fraction. Therefore, ChIP 
results using anti-PML antibodies are difficult to interpret.
A second approach has been used extensively for probing 
the spatial relationships between genes and subnuclear com-
partments such as nuclear speckles (Shopland et al., 2003) and 
transcription factories (Osborne et al., 2004). Immuno-FISH 
combines immunofluorescence microscopy with fluorescence 
in situ hybridization (FISH) and has been used to demonstrate 
the localization of two specific genomic loci with PML NBs, 
the major histocompatibility complex (MHC; Shiels et al., 2001), 
and a region of the genome containing the TP53 gene (Sun et al., 
2003). In spite of this information, immuno-FISH suffers from 
two significant drawbacks. First, it is limited by the resolution of 
light microscopy; genetic elements that are within 50–100 kbp 
of each other are unresolved in the micrographs (Trask et al., 
1989). Second, immuno-FISH requires an a priori basis for se-
lecting a specific locus to probe. Therefore, new or unpredicted 
associations between specific genes and PML NBs cannot be 
discovered with this approach.
To circumvent the limits of ChIP and immuno-FISH, we 
have developed a method called immuno-TRAP, which depos-
its biotin onto only the chromatin that is immediately adjacent 
to potentially any subnuclear structure or compartment. Affin-
ity purification of this biotinylated chromatin then allows for 
further downstream analysis of functional outcomes of such 
an association. Here, we used the PML NB as an example of 
a subnuclear domain to develop immuno-TRAP and demon-
strate its power to identify specific gene loci found to be as-
sociated with this structure (Sun et al., 2003). In addition to 
confirming a previously described association of the TP53 
locus with PML NBs, the advantage of the naive aspect of our 
new method uncovered novel locus–PML NB associations, 
including the ABCA7 and TFF1 loci, and most surprisingly, 
the PML locus itself. We show that these associations are non-
random, are cell type specific, and depend on the physiologi-
cal state of the cell.
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found that the PML locus was indeed enriched at PML NBs 
when probed with the affinity-purified Jurkat DNA. This is the 
first observation of the PML locus being nonrandomly associ-
ated with PML NBs.
The resolution demonstrated with the BAC probes appears 
to be 300 kbp (Fig. 1 D), the same order as the average length 
the TP53 locus. We also detected loci that are less enriched than 
the BCL2 locus. Because of possible regulatory interactions be-
tween both TP53 and PML at both the protein and transcription 
levels (Fogal et al., 2000; de Stanchina et al., 2004), we asked 
whether there was a remote possibility that the PML locus 
itself might also be associated with PML NBs. Surprisingly, we 
Figure 1. Affinity purification of PML NB–associated chromatin using immuno-TRAP. (A) Schematic of the immuno-TRAP protocol. (1) Cells are placed 
or grown on glass slides. (2) Cells are then fixed and permeabilized for immunolabeling for PML protein using a primary antibody against PML (blue) 
and a secondary antibody conjugated with HRP (red). Biotinylated tyramide (orange) and hydrogen peroxide are added to the samples and tyramide 
deposition occurs at PML NBs and the surrounding chromosome territories (CT). (3) Cells are collected and the DNA sheared and affinity purified on 
a streptavidin-agarose column. (B) Verification of the tyramide deposition. Jurkat cells were prepared for immuno-TRAP and treated with anti-PML (+Ab) and 
control anti-FLAG (Ab) antibodies. Tyramide-biotin was detected with streptavidin-Cy3. Tyramide-biotin labeling occurred predominantly around PML 
NBs, visualized by immunofluorescence microscopy with an anti-PML antibody. Images shown are single optical planes from a z stack. Bar, 5 µm. 
(C) DNA gel electrophoresis was performed on three samples: sheared genomic Jurkat DNA (lane 1), immuno-TRAP isolated Jurkat DNA using a control 
anti-FLAG (lane 2), and using an anti-PML antibody (lane 3). Significantly more DNA was isolated when a PML-specific antibody was used compared 
with the control (compare lanes 2 and 3). (D) DNA dot blot analysis was performed to determine which regions within Chr17p13.2-13.1 were enriched 
at PML NBs. See Table S1 for the BACs used. The affinity-purified DNA (AP) and a PCR product against the CAT gene (CAT), used as a normalization 
standard, were radiolabeled and used to probe the membranes. Values plotted on the graph are relative to the BCL2 locus (a putative nonassociated 
locus). Three regions (red circles) near the TP53 locus were more enriched than the BAC containing the TP53 locus itself (arrow). (E) Bar graph comparing 
the enrichment of the PML locus relative to the BCL2 locus and the three highest hits from chromosome 17, measured from the DNA dot blot. Error bars 
in graphs (D and E) represent the standard deviation of three independent sample preparations. Paired t tests confirmed that the peaks were significantly 
enriched over BCL2 (*, P < 0.02; **, P < 0.01). (F) DNA dot blot analysis was performed to determine the resolution capabilities of immuno-TRAP. Six 
FOSMIDs spanning peak 2, the BCL2 BAC, and the BACs flanking and containing peak2 were spotted on a membrane (see Table S1 for FOSMIDs used). 
Probing and normalization was performed similarly as in D. Values plotted are relative to the BCL2 locus. Paired t tests indicated that FOSMID pairs 1 
and 4, and 4 and 5 are significantly different (*, P < 0.05; **, P < 0.10, respectively).
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by immuno-TRAP were significantly more associated than the 
BCL2 locus (P < 0.0001). In addition, there was less variance 
in the data for loci targeted to PML NBs than that of the BCL2 
locus. Thus, we conclude that the loci enriched by the immuno-
TRAP technique are indeed associated with PML NBs.
Locus organization around PML NBs
The FISH results then begged the question of whether these dis-
tinct loci around the TP53 gene associated simultaneously with 
the same PML NB. Jurkat cells were prepared for immuno-
FISH using BAC probes corresponding to both peaks 1 and 2. 
At least one locus was found near a PML NB (where FISH and 
immunofluorescence signal overlapped) in 34% of interphase 
cells. Three PML NB–loci interaction patterns were observed 
(Fig. 2, G–I). The first pattern, where peak 1 was closer to the 
PML NB than peak 2, occurred 43.9% of the time. The second 
pattern, where peak 2 was closer to the PML NB, occurred 
30.6% of the time. Lastly, the third pattern, where the two FISH 
loci were approximately equidistant from the PML NB, oc-
curred 12.2% of the time. This indicates that the loci do indeed 
of the BACs. To determine whether immuno-TRAP can actu-
ally provide higher resolution than this, we performed a similar 
DNA dot blot with FOSMIDs (FOSMIDs used can be found in 
Table S1) that spanned peak 2 (Fig. 1 F). The genomic inserts of 
the FOSMIDs were on average 30 kbp. From this analysis, res-
olution of at least 110 kbp (P < 0.05) is achieved, and possibly 
as high as 32 kbp (P < 0.10).
Although immuno-TRAP provides advantages over 
immuno-FISH, which will be discussed later, immuno-FISH is 
indispensable for confirmation of the gene loci identified by the 
immuno-TRAP result. PML NBs in Jurkat cells were detected 
using an antibody against PML protein, and FISH probes were 
prepared using the same BACs used in the DNA dot blot analy-
sis. As expected, FISH demonstrated that the PML locus and the 
three highest chromosome 17 loci hits do indeed associate with 
PML NBs and with a frequency much greater than that of the 
BCL2 locus (Fig. 2, A–E). This was quantified by mean mini-
mal distance (mmd) analysis between the locus of interest and 
the nearest PML NB (Fig. 2 F). By comparing the box plots of 
the associated loci with the BCL2 box plot, the loci we identified 
Figure 2. Confirmation of loci enrichment at PML NBs with immuno-FISH. (A–E) Jurkat cells were probed with the three BACs from Chr 17p13.2-13.1 that 
gave the highest dot blot signals (Fig. 1, D and E; red) and immunolabeled for PML NBs (green). (F) mmd measurements were obtained from the immuno-
FISH images. In the box plots, the box represents the second and third quartiles, the whiskers represent the minimum and maximum values, the middle 
line represents the median, and an “X” denotes the mean. The three enriched regions found in this study and the PML locus were all significantly more 
associated with PML NBs than the BCL2 locus (P < 0.0001). (G–I) Dual-color immuno-FISH was performed where Jurkat cells were probed against peaks 1 
and 2 (Fig. 1, D and E; red and green, respectively) simultaneously and immunolabeled for PML protein (cyan). The following loci arrangements were 
observed: (G) peak 1 is closer to the PML NB than peak 2 in 43.9% of the measurements, (H) peak 2 is closer to a PML NB than peak 1 in 30.6% of the 
measurements, and (I) both peaks were approximately equidistance from the PML NB. Images shown are single optical planes from a z stack. Broken lines 
outline cell nuclei. Bars, 5 µm.
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spot 4). The BAC used for identifying the PML locus region 
contains three other genes (LOXL1, STOML1, and GOLGA6) 
besides the PML gene itself. Therefore, we can only conclude with 
certainty that the PML locus region becomes associated with 
PML NBs upon IFN treatment. We believe, however, that the 
positions of the genes found within the PML locus also change 
upon IFN treatment and associate at least indirectly with PML 
NBs because they are found within the same genomic region. 
High throughput sequencing could reveal which genes within the 
locus directly associate with PML NBs after IFN treatment.
Promoter association with PML NBs
Past results have shown that DNA viruses such as herpes virus, 
adenovirus, human cytomegalovirus, and SV40 target their ge-
nomes to PML NBs for transcription and replication (Ishov and 
Maul, 1996). In addition, artificially tethering a reporter construct 
to PML NBs affects the transcription of the plasmid (Block et al., 
2006). Therefore, we reasoned that promoters might be in the 
vicinity of PML NBs with possible functional consequences. 
Thus, we performed promoter analysis using the Agilent human 
promoter array with Jurkat DNA obtained with immuno-TRAP. 
To validate the immuno-TRAP microarray results, we used 
associate with the same PML NB, though the actual locus that 
tethers this chromosome region to the PML NB may vary be-
tween cells. Although immuno-TRAP indicates that the loci rep-
resented by peak 2 are more enriched at PML NBs than loci 
represented by peak 1, immuno-FISH shows a slightly higher 
propensity for peak 1 interactions than peak 2. However, the stan-
dard deviation of the interaction measured by the dot blot analy-
sis was greater for peak 2 than peak 1. Our interpretation of this 
minor discrepancy is that the association of peak 2 loci with the 
PML NB is more transient, possibly characterized by an inter-
action with a shorter half-life.
Cell type specificity of PML  
NB–locus associations
We then asked whether the association of particular genes with 
PML NBs is general or displays cell type dependence. Because 
PML NBs are found in regions of high transcriptional activity 
(Wang et al., 2004) and a majority of cell types express PML 
protein, we chose to probe for the association of the PML locus 
with PML NBs in other cell lines. To test this, we performed 
mmd analysis for PML and BCL2 locus association with PML 
NBs in the following cell lines: GM05757 cells (normal human 
diploid fibroblasts), HT1080 cells (derived from a fibrosar-
coma), and SK-N-SH cells (neuroblastoma origin). The FISH 
of GM05757 and SK-N-SH cells displayed no significant as-
sociation of either the PML or BCL2 locus with PML NBs. In 
HT1080 cells, however, the PML locus was significantly more 
associated (P < 0.001) with PML NBs than the control BCL2 
locus (Fig. 3 D). This relationship was similar to that observed 
in Jurkat cells. Therefore, we conclude that associations of 
specific loci, such as the PML locus, with PML NBs are cell 
type dependent.
Creating new PML NB associations
Because PML NBs are found in regions of high transcriptional 
activity, it may be possible to form new PML NB–locus asso-
ciations by changing the transcriptional profile of the cell. To 
test this, we treated GM05757 cells with IFN-. The up-regulation 
of the PML gene and an increase in the number and size of PML 
NBs (Stadler et al., 1995), typically associated with IFN treat-
ment, was confirmed in the GM05757 cells (Fig. 4, A and B). 
Immuno-FISH of GM05757 cells demonstrated that new PML 
NB–locus associations did indeed occur. IFN treatment of 
GM05757 cells resulted in the formation of a specific PML 
NB–PML locus association (Fig. 4 C). Although the number of 
PML NBs increases with IFN treatment, we did not observe an 
association between PML NBs and the BCL2 locus (Fig. 4 C, 
box plot). Thus, we conclude that the association of PML 
NBs with the PML locus observed after IFN treatment was not 
the result of more and larger PML NBs, which could increase the 
random chance of nonspecific interactions, but the result of the 
formation of a bona fide association. This result was confirmed 
using a dot blot analysis with sequences enriched by immuno-
TRAP from GM05757 cells treated with IFN- (Fig. 4 D; see 
Table S1 for BACs used for the dot blot). After normalizing spot 
intensities, it was observed that enrichment for the PML locus 
increased threefold after IFN treatment (compare values for 
Figure 3. Cell type specificity of PML NB loci associations. (A–C) Immuno-
FISH was performed on GM05757, SK-N-SH, and HT1080 cells to deter-
mine if the PML locus association with PML NBs is cell type specific. Cells 
were probed for the PML and BCL2 loci (red) and PML NBs (green). Broken 
lines outline cell nuclei. Bar, 5 µm. (D) Box plots comparing BCL2 and PML 
mmd measurements. The asterisk denotes a significant association (P < 
0.001) between the PML locus and PML NBs observed in HT1080 cells. 
Elements in the box plots are defined the same as in Fig. 2 F. Images 
shown are single optical planes from a z stack.
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Discussion
Our motivation in developing the immuno-TRAP technique was 
to provide an unbiased approach for discovering gene loci as-
sociations with potentially any subnuclear compartment. The 
relative positioning of gene loci to structures, such as transcrip-
tion factories, nuclear bodies, and heterochromatin domains, is 
critical in regulating physiological responses and in genetic pro-
gramming through development. Therefore, methods that define 
these relationships will have enormous value. With this new 
technique, we have verified the association between the TP53 
locus and PML NBs (Sun et al., 2003), but more importantly, we 
uncovered novel gene–PML NB associations.
We have shown that when immuno-TRAP-purified DNA 
is probed with FOSMID fragments, statistically significant 
immuno-FISH. We chose to probe for 11 gene promoters signif-
icantly enriched for PML NB association based on low q-values. 
Besides low q-values, these 11 gene promoters were also found 
within BACs that had previously been FISH-mapped onto the 
human genome (Cheung et al., 2001; Fig. 5). Using the BCL2 
locus as a negative control and the PML locus as a previously 
verified positive control for PML NB association, all 11 loci had 
a significantly higher association than BCL2. More importantly, 
7 of these 11 loci had distributions equal or significantly greater 
than that of PML. Sequences near these promoter elements 
found in their respective BACs could also contribute to the 
PML NB association observed by the immuno-FISH verifica-
tion. Nevertheless, we conclude that these seven loci found on 
the microarray are also able to make bona fide associations with 
PML NBs (see table in Fig. 5).
Figure 4. Creating new locus–PML NBs associations. (A) GM0575 cells were treated with IFN- for 24 h. Protein samples were prepared and Western 
blots were performed showing that PML protein levels increase after IFN-. (Multiple bands correspond to various splice isoforms of PML and posttrans-
lational modifications, i.e., sumoylation.) (B) Immunofluorescence for PML NBs was performed on GM05757 cells, and the number of PML NBs was 
determined. The bar graph shows that PML NBs increased in number after IFN- treatment. (C) Immuno-FISH was performed on GM05757 cells treated 
with IFN- and probed for either the PML or BCL2 locus (red) and with an antibody against PML to detect PML NBs (green). Box plots show that the PML 
locus was significantly more associated than the BCL2 locus after IFN- treatment in GM05757 cells (*, P < 0.0001). Elements in the box plots are defined 
the same as in Fig. 2 F. Broken lines outline cell nuclei. Bar, 5 µm. (D) DNA dot blot analysis was performed on DNA (AP) isolated from IFN-–treated 
GM05757 cells with immuno-TRAP and probed for enrichment against BACs corresponding to BCL2 and five BACs surrounding and including the PML 
locus (see Table S1 for a list of BACs). The CAT gene (CAT) was used as a normalization standard. The bar graph shows relative enrichment for each BAC 
relative to the BCL2 locus. This experiment was performed using three biological replicates and the error bars represent the standard deviation. Images 
shown are single optical planes from a z stack.
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unexpected or unpredicted gene loci associations, with no a 
priori assumptions.
Another question relates to the advantages and disadvan-
tages of ChIP relative to immuno-TRAP. For proteins that bind 
DNA directly, ChIP is able to identify the same loci as immuno-
TRAP, but ChIP would provide much higher resolution in the 
gene domain, on the order of nucleosome resolution. Immuno-
TRAP, however, is more suited to the question of gene loci in-
teractions with specific subnuclear structures, such as nuclear 
bodies. In other words, the question of which genes are asso-
ciated with PML NBs is better answered by immuno-TRAP, 
whereas determining where a protein such as PML binds within 
a gene would be better answered with ChIP. This is true in part 
because of differences in the techniques. In the ChIP procedure, 
cells are cross-linked, then fragmented and homogenized, before 
antibody treatment. In the immuno-TRAP procedure, cells are 
cross-linked, but fragmentation occurs after the antibody step. 
This means that, unlike ChIP, immuno-TRAP benefits from 
antibody-based signal amplification. In addition, the higher the 
local concentration of protein, such as at nuclear bodies, the 
greater the amplification of the signal will be. Therefore, signifi-
cantly more tyramide will be deposited on chromatin around 
nuclear bodies than on chromatin near nuclear-diffuse PML 
protein. This principle, along with the fact that PML does not 
bind DNA directly, weights detection in favor of genes that are 
in the vicinity of nuclear bodies. This, indeed, is what we ob-
served; immuno-FISH confirmed the nuclear body association 
of several loci identified by immuno-TRAP.
Immuno-TRAP provides a good starting point for fur-
ther downstream analysis. For example, we probed two loci for 
their relative configurations around a single PML NB (Fig. 2, 
G–I). Previously we have shown that PML NBs rapidly “jiggle” 
or “twitch” with an amplitude less than their diameter during in-
terphase (Dellaire et al., 2006). Therefore, the variable association 
resolution of loci separated by 30–100 kbp can be attained 
(Fig. 1 F). Hence, immuno-TRAP can achieve at least this degree 
of genetic resolution, and may be able to surpass this resolution 
if even shorter probes were used. Can we relate the resolution 
limits of immuno-TRAP and immuno-FISH? Two gene loci on 
the same chromosome can be resolved by FISH (not immuno-
FISH) if they are separated by at least 100 kbp (Trask et al., 
1989), based on the spatial resolution of light microscopy and 
the estimated 100-fold linear compaction ratio of the DNA. 
However, it is more difficult to determine by immuno-FISH 
which of two closely linked loci (locus A or locus B) actually 
contacts a nuclear substructure such as a PML NB and thereby 
tethers the other locus to the body. The difficulty is particularly 
apparent when the nuclear body is large relative to the 200-nm 
spatial resolution of the microscope. By imaging scores of cells, 
however, it might be possible to determine whether locus A 
tethers locus B or vice versa. This depends on the genomic dis-
tance between the two loci, the degree of compaction of the 
chromatin, and the size of the target, i.e., the dimensions of 
the nuclear body. Our new immuno-TRAP technique is more 
suited to this question because it is based on molecular inter-
actions and not on optics. It also benefits from the statistical 
advantage of sampling millions rather than only scores of cells. 
Ultimately, immuno-TRAP resolution is limited to the molec-
ular dimensions of the primary and secondary antibodies and, 
critically, to the diffusion of activated tyramide away from the 
secondary antibody conjugated with the peroxidase enzyme. 
Modifications of the technique to limit the “blooming” of the 
tyramide signal around PML NBs through manipulating reac-
tion time, tyramide concentration, and temperature may optimize 
both signal strength and spatial resolution. Though the spatial 
resolution of immuno-TRAP demonstrated with the FOSMID 
probes exceeds that attained by immuno-FISH, the major ad-
vantage over immuno-FISH is that immuno-TRAP can reveal 
Figure 5. Promoter analysis and confirmation. 11 loci were chosen and tested by immuno-FISH for possible association with PML NBs. These loci were 
chosen based on significance of the enrichment (low q-values) and on their having been previously FISH-mapped on the human genome. The table on the 
left shows the mmd averages and standard deviations between the locus of interest and PML NBs. The percent association is also shown. The mmd values 
were then compared with the BCL2 and PML loci. The asterisks denote values that are significantly different than BCL2mmd but similar to PMLmmd values (P < 
0.001). Representative immuno-FISH of four loci (red) are shown (right) that demonstrate significant associations with PML NBs (green). Images are derived 
from single optical planes from a z stack. Broken lines outline cell nuclei. Bar, 5 µm.
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present in the unstimulated state. New PML locus–PML NB 
associations were detected by immuno-TRAP and confirmed 
by immuno-FISH (Fig. 4 C). In addition, dot blot analysis re-
vealed a significantly higher enrichment of the PML locus in the 
immuno-TRAP DNA samples after IFN- treatment relative to 
the no treatment control (Fig. 4 D). This result indicates that the 
location of newly formed PML NBs, or the movement of the 
locus and/or a preexisting PML NB toward each other, is a re-
flection of the physiological state of the cell.
By combining immuno-TRAP with high-throughput pro-
moter microarray analysis, we were able to discover novel ge-
nomic loci that associate nonrandomly with PML NBs (Fig. 5). 
One advantage of using the microarray over FISH to find novel 
gene associations is that it provides a larger scope with no a priori 
bias. Microarrays, however, lack the coverage and resolution 
that is provided by deep sequencing techniques. In spite of this 
disadvantage, we were still able to find novel gene associa-
tions. TFF1 is one locus of particular interest because a possible 
mechanistic basis for the association is obvious. The RFP pro-
tein, which is a transcription factor for this gene (Townson et al., 
2006), is also a component of a subset of PML NBs (Cao et al., 
1998). Hence, RFP may be the adaptor that tethers the TFF1 
gene to a PML NB. Further testing is needed to confirm this. 
ABCA7 is another target of interest because of its high expres-
sion in myelolymphatic tissue (Broccardo et al., 2001). Because 
Jurkat cells are T lymphocytes, it is tempting to think that the 
expression of ABCA7 may be affected by its localization at PML 
NBs. Future studies will test this hypothesis.
In summary, immuno-TRAP is a powerful technique for 
tagging and isolating chromatin that is associated with PML 
NBs. The aim of this technique is similar to that of DamID. Like 
immuno-TRAP, DamID tags chromatin associated with a nuclear 
subcompartment, specifically the nuclear lamina (Pickersgill 
et al., 2006). The difference between these two techniques is 
that immuno-TRAP involves aldehyde fixation (as do ChIP and 
3C-based techniques), which could affect subnuclear associa-
tions through altered molecular interactions, whereas DamID 
requires the overexpression of a fusion protein, which could 
also induce nonnative associations. Although DamID has been 
used to tag chromatin located at the nuclear periphery, our 
immuno-TRAP technique can be easily adapted to any subnuclear 
structure for which specific primary antibodies are available. 
The power of immuno-TRAP could be augmented by combin-
ing immuno-TRAP with 3C or any of its derivatives and with 
deep sequencing to examine the chromatin environment of any 
nuclear subcompartment, including the nuclear lamina, nuclear 
pores, nucleolar periphery, late DNA repair foci, nuclear speck-
les, and other nuclear bodies. These combined approaches will 
help us to understand how the positioning of a gene locus in the 
nucleus is related to its regulation.
Materials and methods
Tyramide deposition and affinity purification of DNA
Tyramide deposition was modified from a previous protocol (Chakalova 
et al., 2004). Cells were fixed in 2% paraformaldehyde (Electron Micros-
copy Sciences) in PBS (Wisent) for 10 min at RT and permeabilized in 
0.5% Triton X-100 (Sigma-Aldrich) in PBS for 5 min at RT. In between 
pattern displayed by these two loci could be a result of PML 
NBs jostling between these nearby regions along the chromo-
some. Sample fixation in preparation for immuno-FISH would 
instantly capture or freeze one of these loci in contact with the 
PML NB. In addition, the alternating pattern of high and low 
associations along the chromosomes with the same PML NB 
(Fig. 1 D and Fig. 2, G–I) lead us to conclude that this chromo-
some region forms loops tethered by a PML NB, an idea consis-
tent with the giant loop model (Yokota et al., 1995). This model 
explains how the distances between loci observed through FISH 
can decrease even though genomic distances are increasing. To 
account for this observation, Trask and colleagues (Yokota et al., 
1995) proposed that the chromatin forms loops are created by 
intrastrand protein connections. We suggest that a PML NB may 
function as the intrastrand protein connection for this region of 
Chr17. A similar function of the SATB1–PML protein complex 
was implicated in chromatin looping of the MHC I locus (Kumar 
et al., 2007). ChIP with antibodies against SATB1 and PML 
in combination with the 3C technique was used to identify the 
looped regions of the chromatin. They found PML protein to 
associate with the following genes: HCG4, HLA-G, HLA-A, and 
HCG9. When comparing our array data with the SATB1-PML 
dataset, we were not able to find these genes associating with 
PML NBs using immuno-TRAP. This difference may reflect 
how the datasets were obtained. Kumar et al. (2007) were look-
ing specifically at matrix attachment region (MAR) binding sites 
within the region of Chr6. We, however, analyzed promoter 
enrichment at PML NBs with a combination of immuno-TRAP 
and microarray analysis. It is possible that we did enrich for 
those sequences, but could not detect them because they were 
not represented on our microarray. Although their study dem-
onstrated an involvement of PML protein in chromatin looping 
of the MHC I locus, they did not explore whether PML NBs 
were involved in this process per se.
In addition to discovering new locus associations with PML 
NBs, we also observed that they are cell type specific; the PML 
locus–PML NB association was observed in two of the four cell 
lines we tested (Fig. 3). A cell type dependency for specific as-
sociations could have several explanations. The first is based on 
the heterogeneity of PML NBs. Composition of PML NBs dif-
fers between cell types and even between PML NBs within the 
same cell (Bloch et al., 1999). A particular protein complement 
may define the function of a given body, including the subset of 
genes that cluster around it through the unique repertoire of regu-
latory factors. This principle is observed in ALT cells, where a 
subset of PML NBs associate with telomeric DNA sequences 
and telomere-associated proteins (Yeager et al., 1999). A second 
possible mechanism for cell type dependence of gene associa-
tions could reflect cell type–dependent combinations of the var-
ious PML splice isoforms (Condemine et al., 2006). Whether 
the association of the PML locus with PML NBs in some cell 
types and under defined physiological states represents an op-
portunity for autoregulation will be explored in future studies.
These locus–PML NB associations are not static in the sense 
that new associations can be formed depending on the cellular 
state of the cell. For example, stimulating human fibroblasts 
with IFN led to a de novo PML locus–PML NB association not 
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and GAPDH protein was detected with rabbit anti-PML (Abcam) and rab-
bit anti-GAPDH antibodies (Abcam). A goat anti–rabbit-HRP was used for 
secondary labeling. Detection was performed using Western Lightning Plus 
ECL (PerkinElmer).
DNA dot blot
BACs and FOSMIDs (both from the Children’s Hospital Oakland Research 
Institute) used in this study (see Table S1) were boiled for 5 min, imme-
diately chilled on ice, and spotted on nylon membrane Hybond-N (GE 
Healthcare). The membrane was then baked at 80°C for 2 h. The membrane 
was probed with either the affinity-purified DNA or a PCR product from the 
CAT gene present in the BAC backbone. The CAT PCR product was used to 
normalize the amount of DNA spotted on each membrane. The DNA was 
radiolabeled with [-32P]dATP using the Strip-EZ kit (Ambion). Following 
the manufacturer’s instructions, the membranes were first probed with the 
affinity-purified DNA, stripped, and then probed with the CAT PCR product. 
Images of the membrane were exposed and collected using a STORM 860 
Imager. Spots were quantified using ImageQuant 5.0 (Molecular Dynamics).
3D FISH
Cells were fixed in 2% paraformaldehyde (Electron Microscopy Sciences) 
in PBS for 5 min, washed three times with PBS, permeabilized in 0.5% Triton 
X-100 (Sigma-Aldrich) in PBS for 20 min, washed three times with PBS, and 
kept overnight in a solution of 20% glycerol in PBS at 4°C. The slides were 
then snap frozen in liquid nitrogen and allowed to partially thaw. The 
slides were then placed back into the solution of 20% glycerol in PBS. This 
was repeated for a total of five times. The slides were washed three times 
in PBS and then treated with 0.1 N HCl for 5 min. Cells were then washed 
in 2× SSC and left overnight in a solution of 50% formamide (Invitrogen) 
in 2× SSC. Slides were denatured in a solution of 70% formamide in 
2× SSC warmed to 75°C for 3 min and then immediately placed in a cold 
solution of 70% formamide in 2× SSC. Probes were directly labeled with 
either spectrum green or spectrum orange fluor-conjugated nucleotides and 
obtained from The Centre for Applied Genomics. Probe and human Cot-1 
DNA were mixed in a 2:1 ratio in hybridization buffer (50% formamide, 
10% dextran sulfate, and 50 nM sodium phosphate buffer, pH 7.0, in 2× 
SSC). The hybridization mixture was denatured at 80°C for 5 min and then 
allowed to reanneal at 37°C for 20 min. Hybridization was allowed to 
proceed overnight in a humidified chamber at 37°C. The slides were washed 
three times in 50% formamide in 2× SSC at 42°C, and then washed in 0.5× 
SSC at 60°C. Next, slides were washed three times in PBS. Slides were immuno-
labeled for PML protein as described in the “Immunofluorescence micros-
copy” section and mounted in Vectashield containing DAPI. To determine 
the mmd between PML NBs and a locus of interest: first, z stacks were ob-
tained at 200-nm intervals and the 3D coordinates of the center of mass for 
each focus were determined using ImageJ (National Institutes of Health); 
then the Euclidian distance between any two points was determined.
Microarray analysis
Microarray data were preprocessed largely as described previously 
(Ponzielli et al., 2008), with slight modifications. In brief, the A and B 
chips of this two-array set were considered separately. Array data were 
scanned using a G2565BA DNA scanner (Agilent Technologies) with 
Agilent Scan Control (version 7.0; http://www.chem.agilent.com/Library/
usermanuals/Public/G2566-90017.pdf) using the software parameters: 
5 µm, 61 mm × 21.6 mm, 16-bit TIF images, and no <XDR>. The result-
ing data were quantitated using Agilent Feature Extraction software (ver-
sion 9.5; http://www.chem.agilent.com/Library/usermanuals/Public/ 
ReferenceGuide_050416.pdf) using the software parameters: ChIP-v1_
95_May07. The resulting data were loaded into the R statistical environ-
ment (version 2.8.1; http://cran.r-project.org/bin/windows/base/old/) 
and assessed for spatial and distributional homogeneity; two arrays were 
excluded for having highly atypical intensity distributions, leaving six 
total biological replicates. Data were preprocessed using the variance-
stabilizing normalization algorithm with default parameter settings, as 
implemented in the vsn package (version 3.8.0) of the BioConductor open-
source library (http://bioconductor.org/packages/2.11/bioc/html/vsn.
html; Rocke and Durbin, 2001). Statistical analysis using a linear model 
was then fit to each probe on the array to capture differences between the 
enriched and control channels using the limma package (version 2.16.5; 
http://bioconductor.org/packages/2.11/bioc/html/limma.html) for the 
R statistical environment (version 2.9.0; http://cran.r-project.org/bin/
windows/base/old/). The resulting hits were subjected to an empirical 
Bayes moderation of standard error (Smyth, 2004) and a false-discovery 
rate adjustment for multiple testing (Efron and Tibshirani, 2002). To identify 
fixation and permeabilization, cells were washed in PBS three times. After 
fixation and permeabilization, cells were washed in TS buffer (100 µM 
Tris-HCl and 150 mM NaCl, pH 7.0). Endogenous peroxidase activity 
was quenched with 0.5% H2O2 in TS for 10 min at RT. After another TS 
wash, samples were blocked in 5% donkey serum in TS for 20 min. mAb 
5E10 (a gift from R. van Driel, University of Amsterdam, Netherlands) was 
used to detect PML protein. A secondary antibody conjugated with horse-
radish peroxidase was then added to the samples. Biotinylated tyramide 
(Invitrogen) was diluted in 0.1 M boric acid and 0.003% H2O2 and then 
incubated on the samples for 2 min. Washing the cells three times in TS 
buffer stopped the reaction. After this, the samples were either processed 
for immunofluorescence microscopy or for affinity purification of the PML 
NB–associated chromatin.
For immunofluorescence microscopy, after the TS washes, the sam-
ples were incubated with streptavidin conjugated with Cy3, and PML was 
detected with anti–mouse Cy5. Samples were mounted in Vectashield con-
taining DAPI and imaged as described in the “Immunofluorescence micros-
copy” section.
For affinity purification, the cells were scraped off the slides into an 
Eppendorf tube containing PBS. The samples were pelleted at 2,900 g at 
4°C for 25 min. The pellet was resuspended in 5 M urea, 2 M NaCl, and 
10 nM EDTA. This suspension was then sonicated in a sonicator (Sonica-
tor 3000; Misonix) equipped with a cup horn in an iced water bath with 
the following program (5 s pulse/15 s pause repeated 15 times at power 
level 4). The program was repeated four more times with changes of the 
iced water bath between repetitions. The sample was then centrifuged at 
13,000 rpm for 15 min at 4°C. The supernatant was then dialyzed over-
night in PBS. Streptavidin agarose beads (Invitrogen) were washed three 
times in PBS and the supernatant was incubated with the beads for 3–4 h 
at 4°C. The beads were washed with the following buffers in this order: 
PBS, TSE150 (20 mM Tris, pH 8.0, 1% Triton X-100, 0.1% SDS, 2 mM 
EDTA, and 150 mM NaCl), TSE 500 (20 mM Tris, pH 8.0, 1% Triton 
X-100, 0.1% SDS, 2 mM EDTA, and 500 mM NaCl), and TE (10 mM 
Tris, pH 8.0, and 1 mM EDTA). The beads were collected in TE buffer, 
and the formaldehyde cross-links were reversed by shaking the samples 
at 65°C overnight. The slurry was then treated with 2 µg/ml RNase A 
(Thermo Fisher Scientific) for 30 min at 37°C and then with 100 µg/ml 
proteinase K (Thermo Fisher Scientific) for 6 h at 37°C. The DNA was 
phenol extracted and ethanol precipitated using glycogen as carrier. 
The DNA was amplified using the Whole Genome Amplification (WGA) 
kit (Sigma-Aldrich).
Cell culture
Jurkat cells were cultured in RPMI (Invitrogen) supplemented with 10% FBS 
(Wisent), 10 µg/ml penicillin and streptomycin (Invitrogen), and 2 mM 
l-glutamine (Invitrogen). GM05757 cells were cultured in AMEM (Invitro-
gen) supplemented with 15% FBS (Wisent), 10 µg/ml penicillin and strep-
tomycin (Invitrogen), and 2 mM l-glutamine (Invitrogen). Jurkat cells were 
deposited on poly-l-ornithine (Sigma-Aldrich)-coated slides before process-
ing for tyramide deposition, FISH, and immunofluorescence microscopy. 
GM05757 cells were grown on glass slides for FISH. For the interferon 
treatments, GM05757 cells were treated with 1,000 U/ml of interferon- 
(PBL Interferon Source) for 24 h.
Immunofluorescence microscopy
Cells were fixed in 2% paraformaldehyde (Electron Microscopy Sciences) 
in PBS (Wisent) for 10 min at RT and permeabilized in 0.5% Triton X-100 
(Sigma-Aldrich) in PBS for 5 min at RT. PML protein was detected with mAb 
5E10 (a gift from R. van Driel), and biotinylated tyramide was detected 
with streptavidin conjugated with Cy3 fluor (Sigma-Aldrich). The second-
ary antibody used was donkey anti–mouse Cy3 or Cy5 (Jackson Immuno-
Research Laboratories, Inc.). Coverslips were then mounted using Vectashield 
(Vector Laboratories) containing DAPI. Images were collected using a 
brightfield microscope (IX81; Olympus) equipped with a camera (Cascade 
512; Photometrics) using a 60×, 1.32 NA, oil-immersion objective lens 
and Immersion Oil Type DF (Cargille Laboratories) imaging medium. QED 
InVivo 3.2 (Media Cybernetics) was used to collect images, which were 
processed with Photoshop CS4 (Adobe).
Western blot analysis
Cells were grown in 10-cm culture dishes and were treated with or with-
out IFN- for 24 h. After IFN treatment, cells were harvested and resus-
pended with 9 M urea in 10 mM Tris-HCl, pH 6.8. 6× SDS-PAGE loading 
buffer was added to the cell lysates after quantification with Bradford 
reagent (Bio-Rad Laboratories). Protein samples were resolved on 10% 
SDS-PAGE gels and transferred onto nitrocellulose (GE Healthcare). PML 
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regions of the genome enriched for hits beyond chance, we developed 
a novel permutation-based methodology. We took the union of the A 
and B chips of this two-array set and removed all control probes (those 
having ControlType values other than zero in the Agilent annotation). 
We identified candidate probes as those having log2|Fold Change| > 0 
and padjusted < 0.25. We also restricted this analysis to genomic regions 
represented by more than three unique probes. These relaxed thresholds 
will initially allow up to 25% of hits to be false positives. Next, for each 
gene on the array (using the Agilent annotation field “GeneName”), we 
calculated the number of candidate probes and the mean of the log10|p| 
of the candidate probes. We then randomized the gene-to-data labels 
100,000 times (requiring >160 h of computer processing time) and for 
each randomization calculated the same metrics. We determined the 
fraction of randomizations that exceeded the observed values and used 
this as an estimate of the probability that each gene was enriched relative 
to chance expectations. False-discovery rate adjustments were applied 
separately to the p-value vectors for each metric. Both raw and prepro-
cessed microarray data have been deposited in the GEO repository at 
NCBI under accession GSE40554.
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